Squamous Cell Carcinoma (Lecture 2)

Slide 1 · Esophageal squamous cell carcinoma

Pathogenesis • morphology • spread • clinical consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

By the end of this lecture, learners should be able to:

Relate epidemiologic exposures to carcinogenesis in the squamous-lined esophagus.

Trace squamous dysplasia to invasive growth and interpret characteristic gross and microscopic findings.

Predict local complications and lymph-node spread from anatomy.

Explain why stage at diagnosis strongly determines prognosis.

Slide 3 · Esophageal epithelium and tumor origin

The esophagus is lined by stratified squamous epithelium.

Squamous cell carcinoma arises from this mucosal epithelial compartment.

A precursor squamous dysplastic lesion precedes invasive cancer.

Stratified squamous epithelium

Supporting tissue

Mucosal architecture — simplified schematic

Slide 4 · The two predominant esophageal cancer types

Feature

Squamous cell carcinoma

Adenocarcinoma

Origin

Squamous lining

Gland-forming tumor

Common site

Middle/proximal portions

Distal esophagus

Typical background

Squamous dysplasia

Barrett esophagus

Morphologic cue

Malignant squamous nests

Malignant glands / mucin

Slide 5 · Global distribution is highly uneven

Up to 180-fold

Up to 180-fold

Incidence varies markedly both between countries and within countries.

Variation of up to 180-fold.

Risk is concentrated in several lower-resource communities.

Slide 6 · High-incidence regions

Regions listed by Robbins include Iran, central China, Hong Kong, Brazil, and South Africa.

Risk varies within countries, not solely across national borders.

Geographic clustering motivates inquiry into local exposures.

Iran

Central China

Hong Kong

Brazil

South Africa

Examples listed, not a ranking

Slide 7 · Age and sex patterns

Patterns depend on local disease burden.

The disease occurs predominantly in adults older than 45 years.

Male predominance is described in low-risk regions.

In high-risk regions, this male predominance may disappear.

Slide 8 · Population disparities require careful interpretation

Exposure and context matter.

A large incidence disparity between Americans of African descent and Northern European descent.

Known risk exposures only partially explain that disparity.

Population-level differences should not be misconstrued as an inherent individual biologic risk.

Slide 9 · Risk factors: An integrated framework

Carcinogenic exposure, repeated mucosal damage, inherited susceptibility, and dietary context all contribute.

Multiple risk factors may coexist in one individual.

Associations do not establish that all pathways are equivalent.

Chemical exposures

Chronic injury

Host susceptibility

Diet / regional context

Squamous carcinogenesis

Slide 10 · Alcohol and tobacco act synergistically

Alcohol and tobacco are major associated exposures in Europe and the United States.

Combined exposure increases risk more than either in isolation (synergy).

Their importance varies with the geographic population.

Alcohol

Tobacco

Synergistic risk

Combined exposure is more than an additive association

Slide 11 · Why exposures differ between regions

Etiologic heterogeneity is central to epidemiology.

Substantial incidence occurs where alcohol and tobacco exposure is uncommon.

Additional suspected exposures include nutrition-related factors and environmental mutagens.

No single exposure model explains worldwide disease distribution.

Slide 12 · Nutrition-related risk context

Diet may modify background susceptibility.

Diets deficient in fruits or vegetables are associated with esophageal SCC.

Broader nutritional deficiencies are suspected to contribute in high-risk settings.

These are risk associations; The source does not assign a single molecular mechanism.

Slide 13 · Repeated thermal injury

Frequent consumption of very hot beverages is an associated risk factor.

Repeated mucosal injury as a plausible contributor.

Thermal injury is not established as the sole cause of regional clusters.

Repeated mucosal damage

At-risk squamous mucosa

Possible carcinogenic progression

Conceptual sequence; Precise mechanism is not established

Slide 14 · Food and environmental mutagens

Chemical mutagen exposure is one proposed route.

Suspected exposures include polycyclic hydrocarbons and nitrosamines.

Other mutagenic compounds may occur in fungus-contaminated foods.

Associations in high-risk populations require cautious interpretation.

Slide 15 · Acetaldehyde-associated high-risk setting

An example of a geographically specific exposure.

A high-incidence pocket in western Kenya.

Consumption of mursik, a traditional fermented milk containing acetaldehyde, has been linked to this setting.

This is a site-specific epidemiologic association—not a universal cause of esophageal SCC.

Slide 16 · Caustic esophageal injury

Previous caustic injury is an established clinical risk factor.

A history of severe esophageal injury may define an at-risk clinical context.

Not every patient with caustic injury develops carcinoma.

Repeated mucosal damage

At-risk squamous mucosa

Possible carcinogenic progression

Conceptual sequence; Precise mechanism is not established

Slide 17 · Achalasia as a predisposing condition

Achalasia is associated with increased esophageal cancer risk.

It produces impaired esophageal emptying and stasis in the source chapter.

Its inclusion highlights a clinical condition rather than a direct chemical carcinogen.

Proximal / upper

Middle

Distal / lower

Impaired emptying and stasis

Slide 18 · Plummer–Vinson syndrome

Recognize the named association.

Plummer–Vinson syndrome is listed as a risk factor for esophageal SCC.

Its relevance is identifying an associated clinical syndrome.

The provided SCC section does not quantify attributable risk or specify surveillance protocols.

Slide 19 · Tylosis: Inherited susceptibility

Tylosis is a rare autosomal dominant disorder.

It is marked by hyperkeratosis of palms and soles.

It is strongly associated with esophageal squamous cell carcinoma.

Autosomal dominant tylosis

Palmar / plantar hyperkeratosis

Esophageal SCC association

Inherited clinical association; Not a risk prediction model

Slide 20 · Remote mediastinal radiation

Exposure history may precede symptoms by years.

Prior radiation to the mediastinum predisposes to esophageal carcinoma.

Most associated cases occur at least five years after exposure.

A remote treatment history is relevant during risk assessment.

Slide 21 · Human papillomavirus: Uncertain contribution

Suspected association ≠ confirmed etiologic driver.

Robbins suggests HPV infection might contribute in certain high-risk regions.

The language is explicitly tentative and geographically qualified.

Do not treat HPV as an established universal cause of esophageal SCC.

Slide 22 · Etiology: Synthesis of evidence strength

Association in Robbins

Interpretation

Examples

Prominent

Established risk association

Alcohol; tobacco

Recognized clinical risk

Predisposing condition

Achalasia; caustic injury; tylosis

Suspected contribution

Unresolved etiologic weight

Food mutagens; thermal injury

Possible / uncertain

Do not generalize

HPV in high-risk regions

Slide 23 · Carcinogenesis is a multistep process

Risk exposures / susceptibility

Squamous dysplasia

Invasive squamous carcinoma

Local and distant spread

Neoplastic precursor lesions arise within squamous mucosa.

Invasion permits extension beyond the epithelial compartment.

Schematic sequence

Slide 24 · Squamous dysplasia: Preinvasive precursor

Robbins calls the in situ precursor “squamous dysplasia.”

Comparable lesions may be termed intraepithelial neoplasia or carcinoma in situ at other sites.

The critical transition is progression from epithelial atypia to invasive growth.

Preinvasive

Invasive

Epithelial boundary (horizontal line); Invasion shown at right

Slide 25 · In situ disease versus invasion

In situ / squamous dysplasia

Atypical neoplastic epithelial cells

Preinvasive compartment

No invasion shown in schematic

Invasive squamous carcinoma

Malignant cells extend beneath epithelium

Infiltration into supporting tissues

Capacity for local extension and nodal spread

Conceptual comparison — not a histologic micrograph

Slide 26 · Molecular heterogeneity: Three subtypes

Three molecular genetic subtypes.

Two subtypes are chromosomally unstable.

A rarer third subtype is described as chromosomally stable.

Subtype 1

Nrf2-pathway overlap

Subtype 2

Immune infiltration

Subtype 3

SMARCA4; PIK3CA / PTEN

Biological categories described

Slide 27 · Molecular subtype 1: Oxidative-stress signaling

A distinctive mutational signature, not a temporal cascade.

This molecular subgroup overlaps in mutation patterns with head-and-neck squamous cell carcinoma.

Altered genes include components of the Nrf2 pathway.

The Nrf2 pathway regulates cellular responses to oxidative stress.

Slide 28 · Molecular subtype 2: Immune-associated pattern

A distinct tumor-associated immune phenotype.

Lacks the Nrf2-pathway mutations used to characterize subtype 1.

Displays pronounced immune-cell infiltration.

Increased executioner caspase-7 cleavage is described.

Slide 29 · Subtypes 1 and 2 share cell-cycle alterations

Both are chromosomally unstable.

Mutations or amplifications affect genes associated with cell differentiation and cell-cycle control.

The shared genomic theme does not erase differences between subtypes.

Differentiation control

Cell-cycle regulation

Chromosomal instability

Shared findings in molecular subtypes 1 and 2

Slide 30 · Subtype 3: A rare stable-genome subtype

Chromatin regulation and PI3K-pathway genes feature in this subtype.

An uncommon chromosomally stable subtype.

It carries missense mutations of SMARCA4.

Either PIK3CA or PTEN mutation is also described.

Slide 31 · Molecular subtype comparison

Characteristic

Subtype 1

Subtype 2

Subtype 3

Chromosomal state

Unstable

Unstable

Stable

Distinctive features

Nrf2-pathway lesions

Immune infiltration; caspase-7 cleavage

SMARCA4 and PIK3CA/PTEN

Shared / caveat

Cell-cycle abnormalities

Cell-cycle abnormalities

Uncommon subgroup

Slide 32 · Molecular classifications: Proper use

Subtype ≠ validated clinical treatment guide.

The Robbins discussion is biological taxonomy, not a treatment decision algorithm.

No assay thresholds or routine molecular testing indications are provided in the source.

Avoid inventing predictive biomarkers or clinical actionability from descriptive genomics.

Slide 33 · Anatomical distribution of esophageal SCC

SCC primarily occurs in the proximal esophagus.

Approximately half develop in the middle third.

This contrasts with the distal predominance of adenocarcinoma.

Proximal / upper

Middle

Distal / lower

Slide 34 · Gross lesion evolution

Early gray-white plaque

Larger mucosal lesion

Mass, ulcer or infiltrative wall disease

Stenosis / local invasion

Growth can occur over months to years.

Macroscopic pattern depends on how tumor expands.

Schematic sequence

Slide 35 · Earliest gross appearance

Initial lesions can appear as small, gray-white plaque-like thickenings.

Their subtle appearance contrasts with large symptomatic tumors.

Early recognition matters because superficial disease has better outcomes.

Early gray-white mucosal plaque

Slide 36 · Exophytic growth causes obstruction

Polypoid or exophytic tumors project toward the lumen.

Progressive encroachment physically impedes bolus passage.

Larger lesions contribute to dysphagia and luminal obstruction.

Mass projects inward and narrows lumen

Slide 37 · Ulcerated growth: Surface destruction

Some tumors form an ulcerated mucosal surface.

Tumor ulceration may be accompanied by hemorrhage and sepsis.

Bleeding can contribute to iron-deficiency symptoms.

Ulcerated tumor disrupts mucosal surface

Slide 38 · Diffuse infiltrative growth: A rigid wall

Infiltrative tumors spread within the wall rather than predominantly into the lumen.

Wall thickening and rigidity progressively narrow the passage.

This morphology can produce a stricture-like presentation.

Wall infiltration and rigid stenosis

Slide 39 · Growth-pattern comparison

Pattern

Principal growth direction

Clinical effect

Exophytic

Into the lumen

Mechanical obstruction

Ulcerating

Mucosal destruction

Bleeding / ulcer-related sepsis

Infiltrating

Within the wall

Rigid narrowing and extension

Slide 40 · Squamous differentiation on microscopy

Nests of malignant cells that partially resemble normal squamous epithelium.

Most lesions are moderately to well differentiated.

Cytologic squamous identity does not indicate early stage.

Schematic tumor nests; NOT a clinical histology image

Slide 41 · Tumor nests versus normal epithelium

Normal squamous architecture

Organized stratified epithelial sheet

Compartmentalized surface lining

Native tissue boundaries maintained

Invasive SCC architecture

Disorganized malignant cell nests

Tumor islands within supporting tissue

Tissue architecture disrupted

Conceptual comparison — not a histologic micrograph

Slide 42 · Histologic differentiation and clinical stage

A well-differentiated carcinoma can still be advanced.

Moderate-to-well differentiated morphology is common.

Symptomatic lesions are generally already large and invasive at diagnosis.

Differentiation and anatomic extent are different descriptive axes.

Slide 43 · The critical pathologic question: Invasion

Preinvasive squamous dysplasia remains restricted to the epithelial compartment.

Invasive carcinoma infiltrates deeper tissue.

Anatomic depth and spread must be assessed separately from squamous differentiation.

Preinvasive

Invasive

Epithelial boundary (horizontal line); Invasion shown at right

Slide 44 · Morphology predicts clinical effects

Exophytic mass

Luminal narrowing

Solids → liquids dysphagia

Poor intake / weight loss

Mechanical obstruction links visible growth pattern to symptoms.

More than one gross pattern may coexist in advanced disease.

Schematic sequence

Slide 45 · The esophageal lymphatic network

Esophageal lymphatic channels are rich.

They facilitate circumferential and longitudinal tumor spread.

They also provide routes to regional lymph nodes.

Proximal / upper

Middle

Distal / lower

Longitudinal channels permit wall spread and metastasis

Slide 46 · Intramural satellite tumor nodules

Tumor foci may occur within the wall several centimeters from the main mass.

Satellite nodules reflect noncontiguous-looking intramural spread.

Their existence complicates assumptions based only on visible tumor length.

Proximal / upper

Middle

Distal / lower

Separate intramural tumor foci can be distant from main mass

Slide 47 · Regional nodes depend on tumor level

Upper third: Predominantly cervical lymph nodes.

Middle third: Mediastinal, paratracheal and tracheobronchial nodes.

Lower third: Gastric and celiac nodes.

Upper third

Middle third

Lower third

Cervical

Mediastinal

Gastric / celiac

Slide 48 · Direct invasion of the respiratory tree

Tumor can extend into adjacent tracheobronchial structures.

Associated consequences include pneumonia.

Communication with the airway can produce a tracheoesophageal fistula.

Esophageal wall

Airway

Direct extension / fistula

Conceptual adjacency; Not anatomical scale

Slide 49 · Tracheoesophageal fistula and aspiration

Tumor invades trachea

Fistula forms

Food enters airway

Aspiration / pulmonary symptoms

Aspiration may occasionally be the initial clinical presentation.

A new respiratory complication may signal advanced local extension.

Schematic sequence

Slide 50 · Aortic invasion: Catastrophic hemorrhage

Esophageal SCC can invade the adjacent aorta.

Vascular erosion may cause sudden, massive blood loss.

This is a high-severity complication of advanced local disease.

Esophagus

Aorta

Vascular invasion → massive bleeding

Slide 51 · Mediastinal and pericardial extension

Anatomical proximity determines local hazards.

Local growth can involve mediastinal structures.

Robbins also lists extension toward the pericardium.

The anatomic neighborhood makes a locally advanced lesion dangerous even without distant metastasis.

Slide 52 · Three major routes of disease extension

Route

Tissue direction

Consequence

Luminal

Encroaches on food passage

Dysphagia / obstruction

Contiguous

Invades neighboring organs

Airway disease; aortic hemorrhage

Lymphatic

Along wall and into nodes

Satellites; nodal metastases

Slide 53 · Clinical onset is often insidious

Late recognition is a central diagnostic challenge.

Symptoms can develop gradually as the passage narrows.

Patients may adapt their diet before describing overt obstruction.

The disease can be anatomically advanced when it first becomes clinically apparent.

Slide 54 · Progressive dysphagia has a mechanism

Initially tolerates solids

Increasing luminal narrowing

Switches to softer / liquid foods

Nutritional compromise

A change in food texture may reveal evolving obstruction.

A history of progressive swallowing difficulty warrants evaluation.

Schematic sequence

Slide 55 · Odynophagia and obstruction

Pain and impaired bolus transit are distinct symptoms.

Odynophagia means pain on swallowing.

Dysphagia and odynophagia may coexist in esophageal SCC.

Tumor enlargement can eventually cause marked obstruction.

Slide 56 · Weight loss and debilitation

Mechanical dysphagia reduces nutritional intake.

Tumor cachexia contributes independently to weight loss.

Progressive debilitation in advanced disease.

Obstructed intake

Tumor cachexia

Weight loss and debilitation

Slide 57 · Hemorrhage and iron deficiency

Tumor ulceration may cause bleeding.

Chronic blood loss can produce symptoms of iron deficiency.

Sepsis may also complicate an ulcerated tumor.

Ulcerated mucosa

Hemorrhage

Iron-deficiency symptoms

Slide 58 · An atypical respiratory presentation

An older adult develops cough during meals and recurrent chest symptoms, with only modest previously recognized dysphagia.

What local anatomic complication best explains this presentation?

Think about abnormal communication between esophagus and airway.

Aspiration via tumor-associated tracheoesophageal fistula as an occasional first manifestation.

Slide 59 · Endoscopic detection changes stage at diagnosis

Earlier detection shifts the extent of disease found.

Increasing use of endoscopic screening has led to earlier detection in some settings.

Recognition of superficial lesions is clinically important.

Robbins does not prescribe a universal screening program or eligibility criteria.

Slide 60 · Superficial versus advanced disease

75% at 5 years

75% at 5 years

Approximately 75% 5-year survival for superficial lesions.

Survival is much lower in patients with advanced tumors.

Outcome comparisons are stage-dependent, not an effect estimate for a screening intervention.

Slide 61 · Regional nodal metastasis worsens prognosis

Lymph-node involvement is associated with poor outcome.

Spread reflects progression beyond the primary tumor.

Nodal status adds information beyond gross luminal size.

Local primary tumor

Regional nodal metastasis

Poorer prognosis

Slide 62 · Overall outcome remains unfavorable

Below 20% at 5 years

Below 20% at 5 years

Overall 5-year survival below 20% in the United States.

The figure varies with tumor stage and demographic strata.

It is a textbook cohort-level estimate, not an individual survival prediction.

Slide 63 · Clinical profile: An integrated pattern

Finding

Pathologic explanation

Clinical implication

Progressive dysphagia

Luminal obstruction / rigidity

Often insidious

Weight loss

Poor intake + cachexia

Debilitation

Hemorrhage

Ulceration

Iron-deficiency symptoms

Aspiration

Tracheoesophageal fistula

Airway involvement

Slide 64 · SCC versus adenocarcinoma: Avoid category error

Dimension

Esophageal SCC

Esophageal adenocarcinoma

Typical location

Middle / proximal

Distal

Important antecedent

Squamous dysplasia

Barrett esophagus

Histology

Squamous nests

Gland-forming / mucinous

Risk pattern

Tobacco, alcohol + other risks

GERD / Barrett context

Slide 65 · Case synthesis: Progressive obstruction

A 62-year-old adult reports gradually worsening swallowing difficulty, initially for solids, now also for liquids, with marked weight loss.

Apply morphology, anatomy, and symptoms together.

What gross growth patterns could explain the obstruction?

Which symptoms support a clinically advanced lesion?

Why should nodal evaluation consider the tumor level?

Slide 66 · Case synthesis: Microscopic diagnosis

A biopsy shows malignant nests partially recapitulating squamous epithelium in an esophageal lesion.

Explain your reasoning in three steps.

Which carcinoma histotype is favored?

How does invasion differ from squamous dysplasia?

Why does a differentiated appearance not establish favorable stage?

Slide 67 · Integrated diagnostic reasoning

Symptoms / at-risk context

Find site and gross pattern

Assess squamous morphology + invasion

Assess local and nodal spread

An organ-based interpretation combines risk, tumor architecture, and anatomic extension.

Stage and spread are central to clinicopathologic prognosis.

Schematic sequence

Slide 68 · Key concepts: One-slide synthesis

Anatomic extent is as important as epithelial phenotype.

Etiology is geographically heterogeneous; Tobacco and alcohol are prominent but not exclusive risks.

The neoplasm progresses through squamous dysplasia to invasion and forms plaque-like, exophytic, ulcerated, or infiltrative lesions.

Lymphatic and contiguous spread explain severe complications and nodal involvement.

Superficial diagnosis carries markedly better outcome than advanced symptomatic disease.

Slide 69 · Selected reference and evidence boundaries

Primary teaching source and limitations

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026).

Primary section: esophageal squamous cell carcinoma; comparator discussions: adenocarcinoma, Barrett esophagus, and achalasia.

Molecular subtypes and reported survival estimates should be interpreted in the context of the cited textbook edition.

Current staging, screening policy, and management recommendations require consultation of separate authoritative guidelines.